<DOC>
	<DOCNO>NCT00187018</DOCNO>
	<brief_summary>Osteogenesis imperfecta ( OI ) genetic disease currently know cure . OI cause osteoblast ( bone-forming cell body ) grow poorly , slow growth child disease cause bone bend break easily . Some form osteogenesis imperfecta may cause severe disability even death . In previous research study perform St. Jude , find child treat bone marrow transplant ( infusion healthy immature blood-forming cell ) begin grow faster , mineral ( material help make bone strong ) bone , break bone less often bone marrow transplant . Several month bone marrow transplant however , body growth begin slow . In research study , child osteogenesis imperfecta receive another infusion bone marrow cell without chemotherapy . The marrow cell come bone marrow donor previous bone marrow transplant . It hop remove CD3+ cell ( type white blood cell attack cell like ) donate bone marrow , subject 's body infuse quite safely body growth bone strength increase . The CD3+ cell remove donor bone marrow use machine call CliniMACS System . This machine approve use United States Food Drug Administration ( FDA ) . The use device consider experimental .</brief_summary>
	<brief_title>Marrow Mesenchymal Cell Therapy Osteogenesis Imperfecta : A Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Osteogenesis Imperfecta</mesh_term>
	<criteria>Must previously enrol TOIT protocol St. Jude Children 's Research Hospital Must original bone marrow donor available willing participate donor Normal liver function Hemoglobin &gt; 10gm/dl</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>Collagen Disease</keyword>
</DOC>